Cargando…

GRPR-targeting radiotheranostics for breast cancer management

Breast Cancer (BC) is the most common cancer worldwide and, despite the advancements made toward early diagnosis and novel treatments, there is an urgent need to reduce its mortality. The Gastrin-Releasing Peptide Receptor (GRPR) is a promising target for the development of theranostic radioligands...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Onofrio, Alice, Engelbrecht, Swantje, Läppchen, Tilman, Rominger, Axel, Gourni, Eleni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657217/ https://www.ncbi.nlm.nih.gov/pubmed/38020178 http://dx.doi.org/10.3389/fmed.2023.1250799

Ejemplares similares

Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers
por: D’Onofrio, Alice, et al.
Publicado: (2022)

Editorial: Radiotheranostics: From basic research to clinical application
por: Gareev, Kamil G., et al.
Publicado: (2023)

Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics
por: Silva, Francisco, et al.
Publicado: (2020)

Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022)

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
por: Abouzayed, Ayman, et al.
Publicado: (2020)

Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature
por: Escudero-Castellanos, Alondra, et al.
Publicado: (2023)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
por: Verhoeven, Marjolein, et al.
Publicado: (2023)

Radiotheranostics Practice in India- Advancing to Precision Oncology
por: Kumar, Rakesh, et al.
Publicado: (2022)

Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
por: Mitran, Bogdan, et al.
Publicado: (2019)

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
por: Müller, Cristina, et al.
Publicado: (2018)

Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021)

Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging
por: Duan, Heying, et al.
Publicado: (2022)

Cross‐Isotopic Bioorthogonal Tools as Molecular Twins for Radiotheranostic Applications
por: Rosecker, Veronika, et al.
Publicado: (2019)

Stability Estimation of Gallium Complexes of DOTA Derivatives for Radiotheranostic Applications
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics
por: Martin, Marcel, et al.
Publicado: (2023)

GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
por: Pu, Fan, et al.
Publicado: (2015)

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
por: Imlimthan, Surachet, et al.
Publicado: (2021)

3D printing of radioactive phantoms for nuclear medicine imaging
por: Läppchen, Tilman, et al.
Publicado: (2020)

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy
por: Rybalov, Maxim, et al.
Publicado: (2014)

The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target
por: Takanami, Keiko, et al.
Publicado: (2014)

Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles
por: Marques, Ana, et al.
Publicado: (2022)

Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions
por: Heidari, Pedram, et al.
Publicado: (2018)

Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens
por: Echigo, Hiroaki, et al.
Publicado: (2021)

India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate
por: Singh, Baljinder, et al.
Publicado: (2023)

Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements
por: Santos, Joana, et al.
Publicado: (2015)

Cancer radiotheranostics targeting carbonic anhydrase-IX with (111)In- and (90)Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
por: Iikuni, Shimpei, et al.
Publicado: (2018)

Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical
por: Ghosh, Arijit, et al.
Publicado: (2019)

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics
por: Murce, Erika, et al.
Publicado: (2023)

Pain Inhibits GRPR Neurons via GABAergic Signaling in the Spinal Cord
por: Bardoni, Rita, et al.
Publicado: (2019)

Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer
por: Birindelli, Gabriele, et al.
Publicado: (2021)

Clickable Radiocomplexes With Trivalent Radiometals for Cancer Theranostics: In vitro and in vivo Studies
por: D'Onofrio, Alice, et al.
Publicado: (2021)

(68)Ga-BBN-RGD PET/CT for GRPR and Integrin α(v)β(3) Imaging in Patients with Breast Cancer
por: Zhang, Jingjing, et al.
Publicado: (2018)

Effect of the versatile bifunctional chelator AAZTA(5) on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist
por: Hofstetter, Michael, et al.
Publicado: (2020)

(18)F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging
por: Yang, Min, et al.
Publicado: (2011)

Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System
por: Guo, Jing, et al.
Publicado: (2020)

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
por: Lundmark, Fanny, et al.
Publicado: (2020)

Bi-Functional Radiotheranostics of (188)Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells
por: Huang, Yi-Shu, et al.
Publicado: (2021)

Calculations of binding affinity between C8-substituted GTP analogs and the bacterial cell-division protein FtsZ
por: Hritz, Jozef, et al.
Publicado: (2010)

In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer
por: Bakker, Ingrid L., et al.
Publicado: (2018)

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
por: Abouzayed, Ayman, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vsu7vkcdufv75gn1c156g82t5t